Louisiana State Employees Retirement System’s Protagonist Therapeutics PTGX Stock Holding History

Louisiana State Employees Retirement System’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.25M	Buy	26,500 +400	+2%	+$41.8K	0.05%	356
2026 Q1	$2.75M	Sell	26,100 -800	-3%	-$70.8K	0.05%	378
2025 Q4	$2.35M	Hold	26,900	–	–	0.04%	439
2025 Q3	$1.79M	Sell	26,900 -2,100	-7%	-$119K	0.03%	614
2025 Q2	$1.6M	Buy	29,000 +900	+3%	+$43.2K	0.03%	644
2025 Q1	$1.36M	Sell	28,100 -700	-2%	-$29.3K	0.03%	750
2024 Q4	$1.11M	Buy	28,800 +300	+1%	+$13.1K	0.02%	926
2024 Q3	$1.28M	Buy	+28,500	New	+$1.15M	0.02%	843

Other funds holding PTGX

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Louisiana State Employees Retirement System's PTGX Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its Protagonist Therapeutics (PTGX) stake by 1.5% in Q2 2026, buying an estimated $41.8K and bringing the position to 26,500 shares worth $3.25M. The position accounts for 0.05% of the portfolio, ranked #356.

Louisiana State Employees Retirement System first reported a position in PTGX in Q3 2024 and has held it in 8 quarters since. 69 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

Louisiana State Employees Retirement System held 26,500 shares of Protagonist Therapeutics worth $3.25M as of Q2 2026.
Louisiana State Employees Retirement System bought 400 Protagonist Therapeutics shares in Q2 2026, an estimated $41.8K.
Protagonist Therapeutics made up 0.05% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #356 holding.
Louisiana State Employees Retirement System first reported a position in Protagonist Therapeutics in Q3 2024 and has held it in 8 quarters since.
69 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.